RUNX2 and cancer: Meanwhile, we also analyzed the protein and mRNA expressions of RUNX2, BRG1, and CD44 in the CRC tissues and found that their protein and mRNA levels were more elevated in the CRC tissues than in the adjacent cancer tissues.